The condition is better measured by looking at factors like inflammation, insulin resistance, and glucose tolerance, according to the doctor. In some cases, using BMI can result in “muscular athletes” being labeled as obese, he noted, and people with “normal” BMI can sometimes have “harmful” levels of visceral (abdominal) fat.

According to a September 2024 data brief from the Centers for Disease Control and Prevention (CDC), 40.3 percent of U.S. adults were considered obese between August 2021 and August 2023.

New guidance from a team of health experts around the world proposes expanding the definition of obesity beyond the popular body mass index (BMI) measure.

A group of experts from around the world are proposing an alternative way of defining clinical obesity, eschewing the commonly referenced body max index (BMI) and instead approaching the condition

BMI falls short as a way to measure obesity. Doctors need to also determine whether body fat harms a person's health.

For the first time in over a decade, obesity rates have dropped in the United States. A recent study by the CDC showed that from 2021 to 2023, those rates dropped from 41.9% to 40.3%.

A new study on behalf of Trace One has identified the U.S. states with the healthiest diets. Over the past several decades, the health of the average American has steadily […]

Childhood obesity is on the rise and is becoming an epidemic in our country and worldwide. The consequences of childhood obesity affect long-term physical, emotional, and mental health. The CDC estimates about 1 in 5 children – approximately 14.

Experts suggest redefining obesity diagnosis with BMI, waist size, and health factors to improve treatment accuracy.

A parasitic worm infection, also known as a helminth infection, occurs when parasitic worms, or helminths, infect the body. Helminth infections can cause several health issues, including anemia, pneumonia, malnutrition, abdominal pain, and diarrhea.

According to the Centers for Disease Control and Prevention, more than two in five American adults have obesity, a common and costly chronic disease. Linked to chronic conditions like type 2 diabetes and inflammatory disorders, obesity has been identified as a critical factor in immune system dysfunction.

Data from a Phase Ia single ascending dose study found that ASC30 demonstrated dose-proportional pharmacokinetics, a half-life of up to 60 hours, and superior pharmacokinetic properties compared to other oral GLP-1 receptor agonists.